Comparison of atenolol versus bisoprolol with noninvasive hemodynamic and pulse wave assessment

Journal of the American Society of Hypertension

Volumn 9, Issue 5, 2015, Pages 390-396

  Aparicio, Lucas S ^a   Alfie, José ^a   Barochiner, Jessica ^a   Cuffaro, Paula E ^a   Giunta, Diego H ^a   Elizondo, Cristina M ^a   Tortella, Juan J ^a   Morales, Margarita S ^a   Rada, Marcelo A ^a   Waisman, Gabriel D ^a  

^a HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

Author keywords

Beta blocker; central blood pressure; hypertension; impedance cardiography

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ATENOLOL; BISOPROLOL; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ANTIHYPERTENSIVE AGENT; BIOLOGICAL MARKER;

ADULT; ANTIHYPERTENSIVE THERAPY; AORTA; ARTICLE; AUGMENTATION INDEX; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BRACHIAL ARTERY; BRADYCARDIA; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DIURETIC THERAPY; FEMALE; HEART INDEX; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HEART STROKE VOLUME; HEMODYNAMIC PARAMETERS; HEMODYNAMICS; HUMAN; HYPERTENSION; IMPEDANCE CARDIOGRAPHY; MALE; MIDDLE AGED; MONOTHERAPY; NON INVASIVE PROCEDURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULSE WAVE; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; ANTHROPOMETRY; ARTERIAL STIFFNESS; BLOOD; COMPARATIVE STUDY; DRUG EFFECTS; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR; VASCULAR RESISTANCE;

ANTHROPOMETRY; ANTIHYPERTENSIVE AGENTS; ATENOLOL; BIOMARKERS; BISOPROLOL; CARDIOGRAPHY, IMPEDANCE; CROSS-OVER STUDIES; FEMALE; HEMODYNAMICS; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PULSE WAVE ANALYSIS; RISK FACTORS; VASCULAR RESISTANCE; VASCULAR STIFFNESS;

EID: 84929510265     PISSN: 19331711     EISSN: 18787436     Source Type: Journal    
DOI: 10.1016/j.jash.2015.02.013     Document Type: Article

References (27)

1. P. Larochelle, S.W. Tobe, and Y. Lacourcière β-Blockers in hypertension: studies and meta-analyses over the years Can J Cardiol 30 2014 S16 S22
2. J. López-Sendón, K. Swedberg, J. McMurray, J. Tamargo, A.P. Maggioni, and H. Dargie Expert consensus document on beta-adrenergic receptor blockers Eur Heart J 25 2004 1341 1362
3. B. Williams, P.S. Lacy, S.M. Thom, K. Cruickshank, A. Stanton, and D. Collier Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study Circulation 113 2006 1213 1225
4. I.B. Wilkinson, H. MacCallum, L. Flint, J.R. Cockcroft, D.E. Newby, and D.J. Webb The influence of heart rate on augmentation index and central arterial pressure in humans J Physiol 525 Pt 1 2000 263 270
5. S. Park, M.-Y. Rhee, S.Y. Lee, S.W. Park, D. Jeon, and B.-W. Kim A prospective, randomized, open-label, active-controlled, clinical trial to assess central haemodynamic effects of bisoprolol and atenolol in hypertensive patients J Hypertens 31 2013 813 819
6. W.-J. Zhou, R.-Y. Wang, Y. Li, D.-R. Chen, E.-Z. Chen, and D.-L. Zhu A randomized controlled study on the effects of bisoprolol and atenolol on sympathetic nervous activity and central aortic pressure in patients with essential hypertension PLoS One 8 2013 e72102
7. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification Am J Kidney Dis 39 2002 S1 S266
8. W. Kirch, and K.G. Görg Clinical pharmacokinetics of atenolol-a review Eur J Drug Metab Pharmacokinet 7 1982 81 91
9. G. Leopold Balanced pharmacokinetics and metabolism of bisoprolol J Cardiovasc Pharmacol 8 Suppl 11 1986 S16 S20
10. L.M. Artigao, J.J. Llavador, A. Puras, J. López Abril, M.M. Rubio, and C. Torres Evaluation and validation of Omron Hem 705 CP and Hem 706/711 monitors for self-measurement of blood pressure Aten Primaria 25 2000 96 102
11. E. Agabiti-Rosei, G. Mancia, M.F. O'Rourke, M.J. Roman, M.E. Safar, and H. Smulyan Central blood pressure measurements and antihypertensive therapy: a consensus document Hypertension 50 2007 154 160
12. L.M. Van Bortel, S. Laurent, P. Boutouyrie, P. Chowienczyk, J.K. Cruickshank, and T. De Backer Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity J Hypertens 30 2012 445 448
13. W.G. Kubicek, J. Kottke, M.U. Ramos, R.P. Patterson, D.A. Witsoe, and J.W. Labree The Minnesota impedance cardiograph- theory and applications Biomed Eng (NY) 9 1974 410 416
14. M.A. Rada, P.E. Cuffaro, C.R. Galarza, J. Barochiner, J. Alfie, and M.L. Posadas Martinez Predictive value of non-invasive hemodynamic measurement by means of impedance cardiography in hypertensive subjects older than 50 years of age Clin Exp Hypertens 36 2013 280 284
15. A.W. Quail, F.M. Traugott, W.L. Porges, and S.W. White Thoracic resistivity for stroke volume calculation in impedance cardiography J Appl Physiol 50 1981 191 195
16. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report Circulation 106 2002 3143 3421
17. A.J. Man, A. van den Meiracker, and M.A. Schalekamp The effect of beta blockers on total peripheral resistance J Cardiovasc Pharmacol 8 Suppl 4 1986 S49 S60
18. D.W. Eeftinck Schattenkerk, B. van den Bogaard, M. Cammenga, B.E. Westerhof, E.S.G. Stroes, and B.-J.H. van den Born Lack of difference between nebivolol/hydrochlorothiazide and metoprolol/hydrochlorothiazide on aortic wave augmentation and central blood pressure J Hypertens 31 2013 2447 2454
19. Z. Dhakam, Yasmin, C.M. McEniery, T. Burton, M.J. Brown, and I.B. Wilkinson A comparison of atenolol and nebivolol in isolated systolic hypertension J Hypertens 26 2008 351 356
20. A. Mahmud, and J. Feely Beta-blockers reduce aortic stiffness in hypertension but nebivolol, not atenolol, reduces wave reflection Am J Hypertens 21 2008 663 667
21. N.M. Wheeldon, T.M. MacDonald, N. Prasad, D. Maclean, L. Peebles, and D.G. McDevitt A double-blind comparison of bisoprolol and atenolol in patients with essential hypertension QJM 88 1995 565 570
22. J.A. Cockburn, S.E. Brett, A. Guilcher, A. Ferro, J.M. Ritter, and P.J. Chowienczyk Differential effects of beta-adrenoreceptor antagonists on central and peripheral blood pressure at rest and during exercise Br J Clin Pharmacol 69 2010 329 335
23. R.G. Asmar, G.M. London, M.E.O. Rourke, and M.E. Safar Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patients: a comparison with atenolol Hypertension 38 2001 922 927
24. G.M. London, R.G. Asmar, M.F. O'Rourke, and M.E. Safar Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/indapamide in hypertensive subjects: comparison with atenolol J Am Coll Cardiol 43 2004 92 99
25. K.-T. Ong, S. Delerme, B. Pannier, M.E. Safar, A. Benetos, and S. Laurent Aortic stiffness is reduced beyond blood pressure lowering by short-term and long-term antihypertensive treatment: a meta-analysis of individual data in 294 patients J Hypertens 29 2011 1034 1042
26. M. Kahonen, R. Ylitalo, T. Koobi, V. Turjanmaa, and P. Ylitalo Influences of nonselective, beta(1)-selective and vasodilatory beta(1)-selective beta-blockers on arterial pulse wave velocity in normotensive subjects Gen Pharmacol 35 2000 219 224
27. F.-H. Ding, Y. Li, L.-H. Li, and J.-G. Wang Impact of heart rate on central hemodynamics and stroke: a meta-analysis of β-blocker trials Am J Hypertens 26 2013 118 125